{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:12:03Z","timestamp":1748319123497,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1023\/a:1014469712395","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T20:35:40Z","timestamp":1041107740000},"page":"25-30","source":"Crossref","is-referenced-by-count":4,"title":["No Causal Association Between Inflammation and Chlamydia Pneumoniae in Patients with Chronic Ischemic Arterial Disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Ra\u00fal","family":"Altman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Scazziota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"368022_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R. Ross","year":"1999","unstructured":"Ross, R. 1999. Atherosclerosis. An inflammatory diseases. N. Engl. J. Med.\n340:115\u2013126.","journal-title":"N. Engl. J. Med."},{"key":"368022_CR2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM199704033361409","volume":"336","author":"A. Maseri","year":"1997","unstructured":"Maseri, A. 1997. Inflammation, atherosclerosis, and ischemic events. Exploring the hidden side of the moon. N. Engl. J. Med.\n336:1014\u20131016.","journal-title":"N. Engl. J. Med."},{"key":"368022_CR3","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1161\/01.CIR.96.11.4095","volume":"96","author":"P. Libby","year":"1997","unstructured":"Libby, P., D. Egan, and S. Skarlatos. 1997. Roles of infectious agents in atherosclerosis and restenosis. Circulation\n96:4095\u20134103.","journal-title":"Circulation"},{"key":"368022_CR4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(97)03079-1","volume":"350","author":"J. Danesh","year":"1997","unstructured":"Danesh, J., R. Collins, and R. Peto. 1997. Chronic infections and coronary heart disease: Is there a link? Lancet\n350:430\u2013436.","journal-title":"Lancet"},{"key":"368022_CR5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0735-1097(98)00093-X","volume":"31","author":"J. L. Metha","year":"1998","unstructured":"Metha, J. L., T. G. P. Saldeen, and K. Rand. 1998. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J. Am. Coll. Cardiol.\n31:1217\u20131225.","journal-title":"J. Am. Coll. Cardiol."},{"key":"368022_CR6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.87.4.1130","volume":"87","author":"E. Linnanmki","year":"1993","unstructured":"Linnanmki, E., M. Leinonen, K. Mattila, M. S. Nieminen, V. Valtonen, and P. Saikku. 1993. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation\n87:1130\u20131134.","journal-title":"Circulation"},{"key":"368022_CR7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","volume":"2","author":"P. Saikku","year":"1988","unstructured":"Saikku, P., M. Leinonen, K. Mattila et al. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet\n2:983\u2013985.","journal-title":"Lancet"},{"key":"368022_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.1992.03490010070032","volume":"268","author":"D. H. Thom","year":"1992","unstructured":"Thom, D. H., T. Grayston, D. S. Siscovick, S. P. Wang, N. S. Weiss, and J. R. Daling. 1992. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA\n268:68\u201372.","journal-title":"JAMA"},{"key":"368022_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.ATV.11.3.547","volume":"11","author":"D. H. Thom","year":"1991","unstructured":"Thom, D. H., S. P. Wang, T. Grayston et al. 1991. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscl. Thromb.\n11:547\u2013551.","journal-title":"Arterioscl. Thromb."},{"key":"368022_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-116-4-273","volume":"116","author":"P. Saikku","year":"1992","unstructured":"Saikku, P., M. Leinonen, L. Tenkanen et al. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann. Inter. Med.\n116:273\u2013278.","journal-title":"Ann. Inter. Med."},{"key":"368022_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/hrt.81.3.232","volume":"81","author":"Y. K. Wong","year":"1999","unstructured":"Wong, Y. K., P. J. Gallagher, and M. E. Ward. 1999. Chlamydia pneumoniae and atherosclerosis. Heart\n81:232\u2013238.","journal-title":"Heart"},{"key":"368022_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/clc.4960220206","volume":"22","author":"R. Altman","year":"1999","unstructured":"Altman, R., J. Rouvier, A. Scazziota, R. S. Absi, and C. Gonzalez. 1999. Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease. Clin. Cardiol.\n22:85\u201390.","journal-title":"Clin. Cardiol."},{"key":"368022_CR13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.99.9.1161","volume":"99","author":"P. M. Ridker","year":"1999","unstructured":"Ridker, P. M., R. B. Kundsin, M. J. Stampfer, C. Poulins, and C. H. Hennekens. 1999. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation\n99:1161\u20131164.","journal-title":"Circulation"},{"key":"368022_CR14","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/01.CIR.101.22.2568","volume":"101","author":"K. Ericson","year":"2000","unstructured":"Ericson, K., G. P. Saldeen, O. Lindquist, C. Pahlson, and J. L. Mehta. 2000. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation\n101:2568\u20132571.","journal-title":"Circulation"},{"key":"368022_CR15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(94)93084-8","volume":"343","author":"P. Patel","year":"1994","unstructured":"Patel, P., D. Carrington, D. P. Strachan et al. 1994. Fibrinogen: A link between chronic infection and coronary heart disease. Lancet\n343:1634\u20131635.","journal-title":"Lancet"},{"key":"368022_CR16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/01.ATV.18.4.621","volume":"18","author":"J. G. van der Bom","year":"1998","unstructured":"van der Bom, J. G., M. P. M. de Maat, M. L. Bots et al. 1998. Elevated plasma fibrinogen. Cause or consequence of cardiovascular disease? Arterioscler. Thromb. Vasc. Biol.\n18:621\u2013625.","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"368022_CR17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI1461","volume":"101","author":"Q. Xiao","year":"1998","unstructured":"Xiao, Q., M. J. Danton, D. P. Witte, M. C. Kowala, M. T. Valentine, and J. L. Degen. 1998. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice. J. Clin. Invest.\n101:1184\u20131194.","journal-title":"J. Clin. Invest."},{"key":"368022_CR18","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","volume":"97","author":"P. M. Ridker","year":"1998","unstructured":"Ridker, P. M., R. J. Glynn, and C. H. Hennekens. 1998. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation\n97:2007\u20132011.","journal-title":"Circulation"},{"key":"368022_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","volume":"331","author":"G. Liuzzo","year":"1994","unstructured":"Liuzzo, G., L. M. Biasurci, J. R. Gallimore et al. 1994. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engl. J. Med.\n331:417\u2013424.","journal-title":"N. Engl. J. Med."},{"key":"368022_CR20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","volume":"279","author":"J. Danesh","year":"1998","unstructured":"Danesh, J., R. Collins, P. Appleby et al. 1998. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA\n279:1477\u20131482.","journal-title":"JAMA"},{"key":"368022_CR21","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1161\/01.CIR.96.12.4204","volume":"96","author":"H. Toss","year":"1997","unstructured":"Toss, H., B. Lindahl, A. Siegbahn et al. for the FRISC Study Group. 1997. Prognostic influence of increased fibrinogen and Creactive protein levels in unstable coronary artery disease. Circulation\n96:4204\u20134210.","journal-title":"Circulation"},{"key":"368022_CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","volume":"17","author":"A. Clauss","year":"1957","unstructured":"Clauss, A. 1957. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta. Haematol.\n17:237\u2013246.","journal-title":"Acta. Haematol."},{"key":"368022_CR23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.CIR.99.12.1555","volume":"99","author":"G. Torgano","year":"1999","unstructured":"Torgano, G., R. Cosentini, C. Mandelli et al. 1999. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation\n99:1555\u20131559.","journal-title":"Circulation"},{"key":"368022_CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1053\/euhj.1997.0771","volume":"19","author":"H. Toss","year":"1998","unstructured":"Toss, H., J. Gnarpe, H. Gnarpe, A. Siegbahn, B. Lindahl, and L. Wallentin. 1998. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur. Heart. J.\n19:570\u2013577.","journal-title":"Eur. Heart. J."},{"key":"368022_CR25","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.99.12.1540","volume":"99","author":"J. L. Anderson","year":"1999","unstructured":"Anderson, J. L., J. B. Muhlestein, J. F. Carlquist et al. 1999. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The azithromycin in coronary artery disease: Elimination of myocardial infection with Chlamydia (ACADEMIC) study. Circulation\n99:1540\u20131547.","journal-title":"Circulation"},{"key":"368022_CR26","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.102.15.1755","volume":"102","author":"J. B. Muhlerstein","year":"2000","unstructured":"Muhlerstein, J. B., J. L. Anderson, J. F. Carlquist et al. 2000. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease. Primary clinical results of the academic study. Circulation\n102:1755\u20131760.","journal-title":"Circulation"},{"key":"368022_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/euhj.1998.1283","volume":"20","author":"E. Gurfinkel","year":"1999","unstructured":"Gurfinkel, E., G. Bozovich, E. Beck, E. Testa, B. Livellara, and B. Mautner. 1999. For the ROXIS study group. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. Eur. Heart J.\n20:121\u2013127.","journal-title":"Eur. Heart J."},{"key":"368022_CR28","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1128\/AAC.40.11.2669","volume":"40","author":"C. C. Kuo","year":"1996","unstructured":"Kuo, C. C., L. A. Jackson, A. Lee, and J. T. Grayston. 1996. In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. Antimicrob. Agents Chemother.\n40:2669\u20132670.","journal-title":"Antimicrob. Agents Chemother."},{"key":"368022_CR29","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0140-6736(05)78804-8","volume":"351","author":"D. Martin","year":"1998","unstructured":"Martin, D., J. Bursill, M. R. Qui, S. N. Breit, and T. Campbell. 1998. Alternative hypothesis for efficacy of macrolides in acute coronary syndromes. Lancet\n351:1858\u20131859.","journal-title":"Lancet"},{"key":"368022_CR30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02027218","volume":"38","author":"C. Agen","year":"1993","unstructured":"Agen, C., R. Danesi, C. Blandizzi et al. 1993. Macrolide antibiotics as anti-inflammatory agents: Roxithromycin in an unexpected role. Agents Actions\n38:85\u201390.","journal-title":"Agents Actions"},{"issue":"suppl.B","key":"368022_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/41.suppl_2.47","volume":"41","author":"F. Scaglione","year":"1998","unstructured":"Scaglione, F. and G. Rossoni. 1998. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. J. Antimicrob. Chemother.\n41(suppl. B):47\u201350.","journal-title":"J. Antimicrob. Chemother."},{"key":"368022_CR32","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","volume":"282","author":"M. Visser","year":"1999","unstructured":"Visser, M., L. M. Bouter, G. M. McQuillan, M. H. Wener, and T. B. Harris. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA\n282:2131\u20132135.","journal-title":"JAMA"},{"key":"368022_CR33","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/jama.282.22.2169","volume":"282","author":"J. Danesh","year":"1999","unstructured":"Danesh, J. 1999. Smoldering arteries? Low-grade inflammation and coronary heart disease. JAMA\n282:2169\u20132171.","journal-title":"JAMA"},{"key":"368022_CR34","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V. Pasceri","year":"2000","unstructured":"Pasceri, V., J. T. Willerson, and E. T. H. Yeh. 2000. Direct proin-flammatory effect of C-reactive protein on human endothelial cells. Circulation\n102:2165\u20132168.","journal-title":"Circulation"},{"key":"368022_CR35","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","volume":"103","author":"V. Pasceri","year":"2001","unstructured":"Pasceri, V., J. Chang, J. T. Willerson, and E. T. H. Yeh. 2001. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation\n103:2531\u20132534.","journal-title":"Circulation"},{"key":"368022_CR36","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.102.16.1917","volume":"102","author":"J. B. Muhlerstein","year":"2000","unstructured":"Muhlerstein, J. B., B. D. Horne, J. F. Carlquist et al. 2000. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation\n102:1917\u20131923.","journal-title":"Circulation"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014469712395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1014469712395\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014469712395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:57:05Z","timestamp":1748264225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1014469712395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["368022"],"URL":"https:\/\/doi.org\/10.1023\/a:1014469712395","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"type":"print","value":"0360-3997"},{"type":"electronic","value":"1573-2576"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}